The Accuracy of CHOLINE PET CT in the Diagnosis of Urological Malignancies (GS-PET-2008)

Clalit Health Services

Status: Unknown

Conditions: Urological Malignancies

Study type: Observational

Funder types: Other

Identifiers

NCT00706212

GS-PET-2008

Details and patient eligibility

About

PET CT is one of the imaging tools that are used for staging of urological malignancies.

C11 Choline is a novel isotope with the advantage of its minimal secretion in the urine. This advantage makes it a potentially better metabolic marker then others such as FDG. Preliminary studies showed ~95% sensitivity in the diagnosis of TCC. Our Goal is to continue the evaluation of this method as a diagnostic and follow up tool in different urological malignancies.

Enrollment: 60 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients older then 18 years of age
• Full consciousness and awareness
• suspected to suffer from urological malignancy and a candidate for a surgical procedur

Exclusion criteria

• known secondary malignancy